MANSI PATEL: Open Payments
NPI 1134875180 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 14 payments from 6 companies in 2025. Trend: 2023 $125 · 2024 $911 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $118 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Almatica Pharma LLC | 1 | $29 |
| Alkermes, Inc. | 1 | $17 |
Products named: REXULTI, AUSTEDO XR, COBENFY, FANAPT, LOREEV XR, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across CA — which companies pay providers there.
